Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA panel recommends approval of Paxene

Sep. 22, 1997

First approvals for Lovenox/Clexane in unstable angina/MI

Sep. 22, 1997

Famvir approved by FDA for new indication

Sep. 22, 1997

Phase I results reported for MiKasome

Sep. 22, 1997

Andrx's extended-release diltiazem receives tentative approval

Sep. 22, 1997

Tacrolimus ointment effective in animal model of contact dermatitis

Sep. 19, 1997

Advisory committee recommends approval of Photofrin for early-stage NSCLC

Sep. 19, 1997

FDA panel recommends approval of Anesta's Actiq for cancer pain

Sep. 18, 1997

Biovail licenses diltiazem for Scandinavian market

Sep. 17, 1997

Generic version of pediatric ibuprofen receives tentative approval from FDA

Sep. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...